EyeGate Pharmaceuticals, Inc.
$4.1 M
IPO
Joint Book-Runner
Joint Book-Runner
Joint Book-Runner
Sole Book-Runner
Joint Book-Runner
Sole Book-Runner
Co-Manager
Sole Book-Runner
Sole Book-Runner
Sole Book-Runner
Joint Book-Runner